Patents don’t kill – Marie Barani reports

Patents don’t kill – Marie Barani reports

With the European Commission acting as legislator and regulator, and the European Parliament and Council representing the European executive power, Brussels is home to some of the main European institutions as well as lobbyists. Early July, two ads portraying opposing...

A guide to the most influential, innovative, and powerful figures and teams in the corporate patent industry.

Read more

More Copyright News

Patents don’t kill – Marie Barani reports

With the European Commission acting as legislator and regulator, and the European Parliament and Council representing the European executive power, Brussels is home to some of the main European institutions as well as lobbyists. Early July, two ads portraying opposing...

read more

EIP US announces growth with patent hires

EIP US has announced growth of its patent capability with two specialists joining its Denver office. Peter Scull, a registered US patent attorney with 25 years’ experience, joins EIP from Hamilton DeSanctis & Cha (HDC) where he spent over nine years.  Peter...

read more

Augmenting your IP portfolio is virtually the only way to compete in AR/VR

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP attorneys Christopher Howes, Zachery Olah, Forrest Jones, and Karthik Kumar, discuss the developments in the augmented and virtual reality sphere with advice for protecting innovation.

An interview with Ismat Levin, Senior Vice President, Commercial and Group General Counsel at Synamedia

Ismat talks to The Patent Lawyer about her experiences as in-house counsel,
Synamedia’s current developments, and her inspirations.

A quantitative approach to overcoming § 101 rejections

Patent eligibility rejections under 35 U.S.C. § 101 remain a significant issue for the United States Patent Office (USPTO). The USPTO has issued multiple updates to provide guidance for Examiners on how and when to issue § 101 rejections, and there have been some improvements in the proper use of such rejections. However, the large volume of rejections under § 101 certainly exceeds the narrow “exception” envisioned by the Supreme Court. Without clear policy guidance for § 101 rejections, the rejections are often
inconsistent, unclear, and subjective. This poses a substantial obstacle to efficient and effective patent prosecution.

Why the USPTO does not receive Chevron deference

David L. McCombs, Joseph Matal & Eugene Goryunov of Haynes & Boone explain the difficulties surrounding Chevron deference and why the USPTO is reluctant to take it into account.

A new dress code for patent validity in Brazil: the practical effects of the Supreme Court decision

The Brazilian attorney José Carlos Vaz e Dias of the IP law firm VAZ E DIAS ADVOGADOS addresses the main aspects of the Brazilian Supreme Court decision that challenged the sole paragraph of Art. 40 and how it affected the patent owners of the pharma business on the ability to exploit, license, and enforce the patents.

Why automated patent analysis can be wrong, even when it’s right

Axel Contreras-Alvarez, former IPR Commercialization Manager at Ericsson, evaluates the reliability of software and automated analysis for patent valuation, considering the factors used by algorithms, and with an action plan for those wishing to use such platforms.

Women in IP Leadership

Kristyn Huffman: Paralegal, The Dow Chemical Company
An interview: inspirations, experiences, and ideas for equality.

Women in IP Leadership

Ai-Leen Lim: CEO and Principal Counsel, AWA Asia

Law firm rankings: South America

A comprehensive list of the 10 most well-respected law firms from the South America region.

Compulsory Licensing during COVID-19 – a potentiality in India?

Manisha Singh & Varun Sharma, of LexOrbis, review the potential requirement for compulsory licensing given the devastating effects of COVID-19 in India; how such licensing can be implemented; and the likelihood of government enforcement.

Does a third party infringe a patent right by conducting clinical trials on an original drug?

Osamu Yammomoto explains the impact of the recent Intellectual Property High Court decision, as well as the necessity for reforming the patent system relating to drug marketing approval in Japan.

Unleashing the full potential of innovation data

Ed White, Head of Analytics, IP Group, Clarivate, explains the importance of looking beyond patent volumes and how to extract richer insights from innovation data.

Intellectual Property and sports

Sports are an integral part of everyone’s life. Some people watch athletes, and some are athletes themselves. At the same time, sports life is becoming more comfortable every day thanks to innovation and creativity in the field. Kristina Mulina, of Zuykov and Partners, reports.

The U.S. Patent Office’s guidance on indefiniteness in AIA post-grant proceedings

Haynes and Boone’s experts Eugene Goryunov, David McCombs, Clint Wilkins and Kristina Smith explain the latest USPTO guidance on indefiniteness.

Diversity, equity, and inclusion with Suzanne Wertheim. Chapter 1: an anti-bias vision

In this six-part series Dr. Suzanne Wertheim, of Worthwhile Research & Consulting, talks to The Patent Lawyer about diversity, equity, and inclusion: what it means; the current challenges; DEI in law; gender bias; and what we can all do to improve.

Sign up to our newsletter!

Subscribe to our newsletter to stay up-to-date with all the most pertinent patent stories and news

Would you like to advertise your company in The Patent Lawyer Magazine?

The Patent Lawyer Magazine offers your firm the exclusive opportunity of targeting some of the world’s biggest Patent organizations by bringing you a purely Patent focused magazine.

IP Knowledge Share
Trademark Lawyer Magazine
IP Knowledge Share
The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!